AmpliPhi Biosciences Corporation

Contact
ampliphibio.com
+1 206 623 7612

AmpliPhi Biosciences Corporation

601 Union Street, Suite 4200
WA 98101 Seattle
USA
+1 206 623 7612
ampliphibio.com
Contact
Profile News
Contact

About AmpliPhi Biosciences Corporation

AmpliPhi BioSciences Corporation, created in 2011 through the merger of Biocontrol Limited with Targeted Genetics Inc., is a biotechnology company dedicated to the development of innovative anti-bacterial solutions to improve human health through the application of its proprietary bacteriophage platform. The Company’s lead product development programs are targeting Gram-negative infections that are often resistant to existing antibiotic treatments.

Read more about AmpliPhi Biosciences Corporation
Facts about AmpliPhi Biosciences Corporation
  • Industry : Biotechnology

News about AmpliPhi Biosciences Corporation

AmpliPhi Biosciences Corporation

21-Sep-2015 | research and development

AmpliPhi announces pre-clinical data

Efficacy of a bacteriophage cocktail is comparable to Vancomycin in S. aureus lung infection model

Read news
AmpliPhi Biosciences Corporation

08-Jun-2015 | politics & laws

AmpliPhi’s Bacteriophage Manufacturing Facility Receives cGMP Certification

First cGMP-certified manufacturing facility commissioned to manufacture bacteriophage products for human use

Read news
AmpliPhi Biosciences Corporation

05-May-2015 | people

AmpliPhi Biosciences Announces New CEO

AmpliPhi BioSciences Corporation announced that Scott Salka has been appointed as the new CEO. Mr. Salka will replace Interim CEO and Chairman of AmpliPhi ...

Read news
AmpliPhi Biosciences Corporation

07-Apr-2015 | research and development

AmpliPhi Granted European Patent for Bacteriophage Therapy to Fight Biofilm-related Bacterial Infections

AmpliPhi BioSciences Corporation announced that the European Patent Office (EPO) has granted European patent no. EP 2570130, “Bacteriophage-containing ...

Read news
AmpliPhi Biosciences Corporation

20-Nov-2012 | business & finance

AmpliPhi and Special Phage Services complete merger

AmpliPhi Biosciences Corporation and Special Phage Services (SPS) are formally combined following the completion of the share exchange transaction. Now ...

Read news
AmpliPhi Biosciences Corporation

13-Sep-2012 | business & finance

AmpliPhi to combine with Special Phage Services to create anti-infective company focused on bacteriophage-based therapies

AmpliPhi Biosciences Corporation announced that it has offered to acquire Special Phage Services (“SPS”). The combination of the two companies would result ...

Read news
AmpliPhi Biosciences Corporation

21-Nov-2011 | business & finance

AmpliPhi Biosciences announces first closing of $2.7m

AmpliPhi Biosciences Corporation has announced that is has closed on an initial  amount of $2.7M in equity investment and convertible loan notes to support ...

Read news
AmpliPhi Biosciences Corporation

14-Nov-2011 | people

AmpliPhi Biosciences appoints Philip J. Young as President and CEO

AmpliPhi Biosciences Corporation  has announced the appointment of Philip J. Young as President and Chief Executive Officer (CEO).Mr. Young, who is based ...

Read news
Show more news about AmpliPhi Biosciences Corporation

Here you will find AmpliPhi Biosciences Corporation